Toyama Chemical Co., Ltd.
http://www.toyama-chemical.co.jp/en
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Toyama Chemical Co., Ltd.
BioNTech Banks On Oncology Pipeline As COVID Cash Dries Up
Like rival Moderna, company reported a steep drop in revenue, but it is still prioritizing its COVID-19 vaccine as an investment priority, while also moving ahead with multiple deals with China-based firms.
Can BioNTech Take China Early-Stage Biotech Innovation Global?
BioNTech is betting on China's innovative capabilities by inking multiple deals with local startups to expand its pipeline beyond mRNA vaccines.
BI Prepares For Regulatory Filings After Spevigo Successfully Prevents GPP Flares
The German firm’s Spevigo seems set to dominate the generalized pustular psoriasis market after it reduced the risk of flares in the pivotal EFFISAYIL 2 trial, triggering label expansion plans less than a year after it was approved for flare treatment.
After Jounce, Concentra Pounces On Atea
Concentra's unsolicited bid for Atea is the latest proof that promising but financially strapped biotechs that are trading below cash are prime M&A targets.
Company Information
- Other Names / Subsidiaries
-
- FUJIFILM Holdings Corporation
- FUJIFILM Group
- Cellular Dynamics International, Inc.
- Opsis Therapeutics
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice